A
Arthex Biotech
Biotech & Life Sciences · Paterna, Spain · Founded 2019
Focused on the research and development of novel oligonucleotide therapies that modulate microRNA to treat diseases with unmet medical needs MoreLess
Developer of anti-microRNAs designed for the treatment of diseases with unmet needs. The company develops drugs and therapies that are designed to treat a variety of disorders in which microRNAs play a role, enabling medical professionals to get access to therapy that helps treat patients suffering from genetic diseases, rare diseases, and diseases with high medical needs. Keywords: Pharmaceuticals and Biotechnology, Antisense Oligonucleotide, Antisense Oligonucleotide Therapy, Muscular Dystrophy, Neuromuscular Disease, Neuromuscular Disease Therapeutics, Neuromuscular Disease Treatment, Neuromuscular Therapy, Oligonucleotide Therapeutics, Oligonucleotide Therapy.
Company overview
Arthex Biotech company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Paterna, Spain
- Employees
- 29
- Open positions
- None listed
- Dealroom signal
- 76.2
Valuation & funding
Arthex Biotech funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Sep 2025 | $81M | $325M | CDTI · Columbus Venture Partners · AdBio partners · Sound Bioventures | ↗ |
| EARLY VCOther financing | May 2023 | $46M | $185M | Hadean Ventures · Sound Bioventures · EIC Fund · Columbus Venture Partners | ↗ |
| DEBTDebt | Mar 2023 | $12M | — | European Investment Bank | ↗ |
| EARLY VCOther financing | Oct 2022 | $0 | — | EIC Fund | — |
| GRANTOther financing | Jun 2022 | $2.5M | — | European Innovation Council | — |
| EARLY VCOther financing | Jun 2022 | EIC Fund | — | ||
| SUPPORT PROGRAMOther financing | Jan 2022 | EIT Health | — | ||
| SUPPORT PROGRAMOther financing | Sep 2021 | EIT Health | — | ||
| SEEDOther financing | Jul 2020 | AdBio partners · Invivo Partners | — | ||
| SEEDOther financing | Jul 2020 | AdBio partners · Invivo Partners · CDTI Innvierte | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $37K | 0% | −$429K | -1159.2% |
| 2025 | $37K | 0% | −$429K | -1159.2% |
| 2024 | $37K | 0% | −$429K | -1159.2% |
| 2023 | $37K | 0% | −$429K | -1159.2% |
| 2022 | $37K | 0% | −$429K | -1159.2% |
| 2021 | $37K | +50.2% | −$429K | -1159.2% |
| 2020 | $25K | — | −$145K | -590.3% |
Growth signals
Arthex Biotech website traffic
Latest recorded traffic for Arthex Biotech is 1.9K monthly website visits, up 18.8% over the last three months. Arthex Biotech's team grew 3.6% over the past year.
Comparisons
Arthex Biotech compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Arthex Biotech's talent
Source: Dealroom Talent Intelligence.
Investors
15 investors on Arthex Biotech's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where Arthex Biotech has talent and traffic
team presence
In the news
Latest news about Arthex Biotech
Recent press, funding announcements, and product moves mentioning Arthex Biotech — open to read from the original sources.
Market sentiment
What the market is saying about Arthex Biotech
An AI-synthesized read of the highest-engagement posts about Arthex Biotech on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arthex Biotech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.